Demonstrates a causal effect of elevated anti-EBNA1 IgG levels on MS risk, suggesting EBV's role in disease.
These results support a unidirectional causal effect of elevated anti-EBNA1 IgG levels on MS risk, reinforcing the role of EBV-related immune responses in MS pathogenesis.
No takes yet. Share an insight, caveat, or question.
Nova et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: